CLASS II ONGOING Device recall · Reported 27 Nov 2024 · FDA Enforcement Report

Abbott Navitor Titan, Vision Technology recalled by Abbott Medical

Abbott Medical is recalling Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, Nvro-35, distributed in New York. The recall was initiated on 17 Oct 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI (GTIN): 05415067045768, Serial Numbers: 20078589, 20357219, 20357226, 20357685, 20358319, 20358343, 20358351, 20358363, 20358368, & 20358370.
Quantity recalled1 US, 9 OUS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0491-2025
FDA event ID
95627
Recalling firm
Abbott Medical, Saint Paul, MN
Classification
Class II
Status
Ongoing
Recall initiated
17 Oct 2024
FDA classified
20 Nov 2024
Reported
27 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

17 Oct 2024Recall initiated by company
20 Nov 2024Classified by FDA+34 days
27 Nov 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, 35 mm, NVRO-35, Sterile

Where it was distributed

New York, Australia, Belgium, Germany, Iran, Israel, Japan, Kazakhstan, Oman, Poland, Romania, Slovakia, Spain, Turkey, United Kingdom.

New York

Questions about this recall

Is Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, Nvro-35 recalled?

Yes. Abbott Medical recalled Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, Nvro-35 on 17 Oct 2024. The recall is Class II and its status is Ongoing. Recall number Z-0491-2025.

Why was it recalled?

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Which lots are affected?

UDI-DI (GTIN): 05415067045768, Serial Numbers: 20078589, 20357219, 20357226, 20357685, 20358319, 20358343, 20358351, 20358363, 20358368, & 20358370.

Where was it sold?

New York, Australia, Belgium, Germany, Iran, Israel, Japan, Kazakhstan, Oman, Poland, Romania, Slovakia, Spain, Turkey, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott Medical

All 33

Other Heart & Vascular Devices recalls

All 6,199